Cargando…
抗体偶联药物在肺癌中的研究进展与展望
Antibody drug conjugates (ADCs) are a novel class of anti-cancer drugs, which combined the specificity of monoclonal antibodies with the cytotoxic palyload via the linkers. Many ADCs have not only verified impressive activity in a variety of cancers, including breast cancer and hematological system...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346152/ https://www.ncbi.nlm.nih.gov/pubmed/35899443 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.22 |